How large is the MIS sacroiliac joint fusion market?

In 2027 the market for MIS sacroiliac joint fusion is valued at USD 1.16 Billion.

What is the expected industry size of MIS sacroiliac joint fusion by 2036?

MIS Sacroiliac Joint Fusion Market size was valued at USD 1.05 Billion in 2026 and is anticipated to grow at 12.58% CAGR from 2027 to 2036, surpassing USD 3.43 Billion by 2036.

Which clinical trends are accelerating adoption of minimally invasive sacroiliac joint fusion procedures?

Growing demand for effective chronic pain management and less invasive surgical approaches is encouraging healthcare providers to adopt procedures that reduce recovery burden, improve outcomes, and optimize surgical efficiency.

How are technological advancements influencing MIS sacroiliac joint fusion procedures?

Innovations in implant systems, imaging guidance, and surgical instruments are improving procedural precision, supporting accurate implant placement, and enhancing confidence in minimally invasive fusion techniques.

Why are implants the leading product segment in the MIS sacroiliac joint fusion market?

Implants dominated with a 61.73% share in 2026 because they enable durable joint stabilization, improved fusion outcomes, and enhanced minimally invasive procedure effectiveness.

How is the anterior approach segment expanding in MIS sacroiliac joint fusion?

The anterior approach is the fastest-growing segment as improved imaging guidance and surgical techniques support individualized planning, better implant placement, and broader minimally invasive treatment adoption.

Why does North America lead the MIS sacroiliac joint fusion market?

North America led in 2026 due to advanced healthcare infrastructure, established minimally invasive procedure adoption, specialized facilities, and experienced clinicians.

What is driving MIS sacroiliac joint fusion growth in Asia Pacific?

Asia Pacific is expanding as healthcare infrastructure, specialist training, and access to advanced orthopedic procedures improve alongside demand for minimally invasive treatments.

Who holds a significant market share in the MIS sacroiliac joint fusion landscape?

Major companies in the MIS sacroiliac joint fusion market include SI-BONE, Inc. (United States), Medtronic plc (Ireland), Globus Medical, Inc. (United States), Zimmer Biomet Holdings, Inc. (United States), Orthofix Medical Inc. (United States), PainTEQ (United States), Life Spine, Inc. (United States), SIGNUS Medizintechnik GmbH (Germany), CoreLink Surgical (United States), Xtant Medical Holdings, Inc. (United States)